ID: ALA281071

Max Phase: Preclinical

Molecular Formula: C14H22O

Molecular Weight: 206.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)c1cccc(C(C)(C)C)c1O

Standard InChI:  InChI=1S/C14H22O/c1-13(2,3)10-8-7-9-11(12(10)15)14(4,5)6/h7-9,15H,1-6H3

Standard InChI Key:  DKCPKDPYUFEZCP-UHFFFAOYSA-N

Associated Targets(Human)

GABA-A receptor; alpha-1/beta-2/gamma-2 1171 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Carbonic anhydrase I 13240 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Carbonic anhydrase II 17698 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glycine receptor alpha-3/beta 286 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Xenopus laevis 337 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

L1210 27553 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Glycine receptor subunit alpha-3 4 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 206.33Molecular Weight (Monoisotopic): 206.1671AlogP: 3.99#Rotatable Bonds: 0
Polar Surface Area: 20.23Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.26CX Basic pKa: CX LogP: 4.76CX LogD: 4.76
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.68Np Likeness Score: -0.03

References

1. James R, Glen JB..  (1980)  Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents.,  23  (12): [PMID:7452689] [10.1021/jm00186a013]
2. Krasowski MD, Hong X, Hopfinger AJ, Harrison NL..  (2002)  4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor.,  45  (15): [PMID:12109905] [10.1021/jm010461a]
3. Selassie CD, Kapur S, Verma RP, Rosario M..  (2005)  Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.,  48  (23): [PMID:16279782] [10.1021/jm050567w]
4. Sentürk M, Gülçin I, Daştan A, Küfrevioğlu OI, Supuran CT..  (2009)  Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols.,  17  (8): [PMID:19231207] [10.1016/j.bmc.2009.01.067]
5. PubChem BioAssay data set, 
6. PubChem BioAssay data set, 
7. Cioffi CL..  (2018)  Modulation of Glycine-Mediated Spinal Neurotransmission for the Treatment of Chronic Pain.,  61  (7): [PMID:28876062] [10.1021/acs.jmedchem.7b00956]